Marek Petecki



+44 (0)20 7400 8000

Marek advises on a wide range of corporate and commercial matters, including mergers & acquisitions, debt and equity financings (including IPOs and secondary public offers), and joint ventures.  

View Marek's practice profile here

"The ‘knowledgeable, calm, pragmatic and extremely responsive’ Marek Petecki advised AstraZeneca UK on the $215m sale of its rights in prescription medicine, Entocort, to Tillots." - f
- Legal 500 2016